Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 1

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 5OTHER 4

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

CNS 2Tumor-Agnostic 1Thoracic 1

Conditions

Neoplasm Metastasis 1Lung Neoplasms 1Glioma 1Glioblastoma 1Astrocytoma 1Adenocarcinoma 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Cancer Vaccines × Clear all
NCT03879512 2024-09-19

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

Wuerzburg University Hospital

Phase 1/2 Completed
24 enrolled
CNS

Astrocytoma, Glioma

NCT05101356 2024-05-21

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

University of California, Davis

Phase 1/2 Recruiting
77 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasm Metastasis

NCT03807102 2023-12-29

TVATLC01

Hunan Province Tumor Hospital

Phase 1/2 Unknown
30 enrolled
Thoracic

Lung Neoplasms

NCT01702792 2018-04-04

Derivation of Tumor Specific Hybridomas

Dartmouth-Hitchcock Medical Center

Phase 1 Terminated
1 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡